Aligos Therapeutics (ALGS) Shareholder's Equity Growth (1y) (2020 - 2026)
Aligos Therapeutics (ALGS) Shareholder's Equity Growth (1y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Aligos Therapeutics |
54.72 Mn |
-25.11 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-72.70% |
| Dec 31, 2025 |
284.81% |
| Sep 30, 2025 |
43.39% |
| Jun 30, 2025 |
51.52% |
| Mar 31, 2025 |
94.74% |
| Dec 31, 2024 |
-131.47% |
| Sep 30, 2024 |
-8.62% |
| Jun 30, 2024 |
-3.46% |
| Mar 31, 2024 |
-29.44% |
| Dec 31, 2023 |
-11.38% |
| Sep 30, 2023 |
-55.07% |
| Jun 30, 2023 |
-49.16% |
| Mar 31, 2023 |
-44.57% |
| Dec 31, 2022 |
-43.76% |
| Sep 30, 2022 |
-43.78% |
| Jun 30, 2022 |
-18.89% |
| Mar 31, 2022 |
-21.69% |
| Dec 31, 2021 |
-16.05% |
| Sep 30, 2021 |
258.79% |
| Jun 30, 2021 |
261.50% |
